![]() |
|||
|
Safe and Unsafe Drugs.It has become increasingly clear that it is often extremely difficult to predict whether a particular drug will be safe in a patient with porphyria or not. Individual subjects vary in their susceptibility to drugs, even to those well-established as precipitants of the acute attack such as the barbiturates. As a result, some health bodies have moved away from a rigid reliance on drug safety lists to a culture based on "safe behaviour". Avoidance of recreational drugs or combinations of drugs is recommended. Where drugs are necessary, perusal of a safe drug list for the safest alternative is recommended. The following lists are based on the best information available to us at the time of compilation. Inclusion of a drug does not guarantee that it will be safe in all circumstances. In Australia, Professor Michael Moore has an accessible and accurate summary of the porphyrias available at www.uq.edu.au/porphyria. The list, however, is now 6 years old. Cardiff University in the United Kingdom has a list, updated late 2005: The University of Cape Town, South Africa, has extensive information for patients and doctors, and is recommended for Varegate Porphyria. The Norwegian Porphyria Centre (NAPOS) has been responsible for the development of the porphyria drug database in multiple languages: The European Porphyria Initiative has a list of Safe and Unsafe drugs: The Canadian Porphyria Foundation has a list of Safe and Unsafe drugs:
Keywords: |
|||||||||||||||